These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26806100)

  • 1. Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT.
    Pan ML; Mukherjee MT; Patel HH; Patel B; Constantinescu CC; Mirbolooki MR; Liang C; Mukherjee J
    Synapse; 2016 Apr; 70(4):163-76. PubMed ID: 26806100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Nguyen GAH; Liang C; Mukherjee J
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
    Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G
    Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Sandhu YK; Bath HS; Shergill J; Liang C; Syed AU; Ngo A; Karim F; Serrano GE; Beach TG; Mukherjee J
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of [
    Reddy TT; Iguban MH; Melkonyan LL; Shergill J; Liang C; Mukherjee J
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.
    Ito H; Shinotoh H; Shimada H; Miyoshi M; Yanai K; Okamura N; Takano H; Takahashi H; Arakawa R; Kodaka F; Ono M; Eguchi Y; Higuchi M; Fukumura T; Suhara T
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):745-54. PubMed ID: 24233004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
    Yousefi BH; Manook A; Grimmer T; Arzberger T; von Reutern B; Henriksen G; Drzezga A; Förster S; Schwaiger M; Wester HJ
    ACS Chem Neurosci; 2015 Mar; 6(3):428-37. PubMed ID: 25482310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosynthesis and evaluation of [11C]BTA-1 and [11C]3'-Me-BTA-1 as potential radiotracers for in vivo imaging of beta-amyloid plaques.
    Neumaier B; Deisenhofer S; Fürst D; von Arnim CA; Thees S; Buck AK; Glatting G; Landwehrmeyer GB; Krause BJ; Müller HD; Sommer C; Reske SN; Mottaghy FM
    Nuklearmedizin; 2007; 46(6):271-80. PubMed ID: 18084683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
    Yousefi BH; Manook A; Drzezga A; von Reutern B; Schwaiger M; Wester HJ; Henriksen G
    J Med Chem; 2011 Feb; 54(4):949-56. PubMed ID: 21275403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
    Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
    J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct binding of amyloid imaging ligands to unique amyloid-β deposited in the presubiculum of Alzheimer's disease.
    Ji B; Chen CJ; Bando K; Ashino H; Shiraishi H; Sano H; Kasahara H; Minamizawa T; Yamada K; Ono M; Zhang MR; Seki C; Farde L; Suhara T; Higuchi M
    J Neurochem; 2015 Dec; 135(5):859-66. PubMed ID: 26315807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular imaging of beta-amyloid plaques in the brain].
    Ono M
    Brain Nerve; 2007 Mar; 59(3):233-40. PubMed ID: 17370649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of PiB binding to white matter in Alzheimer disease and other dementias.
    Fodero-Tavoletti MT; Rowe CC; McLean CA; Leone L; Li QX; Masters CL; Cappai R; Villemagne VL
    J Nucl Med; 2009 Feb; 50(2):198-204. PubMed ID: 19164220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for beta-amyloid plaques in Alzheimer's disease.
    Cui MC; Li ZJ; Tang RK; Liu BL
    Bioorg Med Chem; 2010 Apr; 18(7):2777-84. PubMed ID: 20211565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
    Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
    Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
    Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
    Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody engagement with amyloid-beta does not inhibit [
    Xiong M; Dahlén A; Roshanbin S; Wik E; Aguilar X; Eriksson J; Sehlin D; Syvänen S
    J Neurochem; 2024 Sep; 168(9):2601-2610. PubMed ID: 38721627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
    Snellman A; Rokka J; Lopez-Picon FR; Eskola O; Wilson I; Farrar G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1784-95. PubMed ID: 22801729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.